Logo image of B4B.DE

METRO AG (B4B.DE) Stock Fundamental Analysis

FRA:B4B - Deutsche Boerse Ag - DE000BFB0019 - Common Stock - Currency: EUR

5.33  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to B4B. B4B was compared to 24 industry peers in the Consumer Staples Distribution & Retail industry. B4B may be in some trouble as it scores bad on both profitability and health. B4B has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year B4B has reported negative net income.
B4B had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: B4B reported negative net income in multiple years.
In the past 5 years B4B always reported a positive cash flow from operatings.
B4B.DE Yearly Net Income VS EBIT VS OCF VS FCFB4B.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

B4B has a Return On Assets of -1.41%. This is in the lower half of the industry: B4B underperforms 70.83% of its industry peers.
B4B has a Return On Equity of -9.95%. This is in the lower half of the industry: B4B underperforms 75.00% of its industry peers.
B4B has a Return On Invested Capital of 2.36%. This is in the lower half of the industry: B4B underperforms 75.00% of its industry peers.
Industry RankSector Rank
ROA -1.41%
ROE -9.95%
ROIC 2.36%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
B4B.DE Yearly ROA, ROE, ROICB4B.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

The Operating Margin of B4B (0.58%) is worse than 75.00% of its industry peers.
In the last couple of years the Operating Margin of B4B has declined.
The Gross Margin of B4B (16.26%) is worse than 75.00% of its industry peers.
In the last couple of years the Gross Margin of B4B has remained more or less at the same level.
Industry RankSector Rank
OM 0.58%
PM (TTM) N/A
GM 16.26%
OM growth 3Y-26.08%
OM growth 5Y-24.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.57%
GM growth 5Y-0.91%
B4B.DE Yearly Profit, Operating, Gross MarginsB4B.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so B4B is destroying value.
B4B has about the same amout of shares outstanding than it did 5 years ago.
B4B.DE Yearly Shares OutstandingB4B.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2024 100M 200M 300M
B4B.DE Yearly Total Debt VS Total AssetsB4B.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2024 5B 10B 15B

2.2 Solvency

B4B has an Altman-Z score of 2.20. This is not the best score and indicates that B4B is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.20, B4B is doing worse than 70.83% of the companies in the same industry.
B4B has a debt to FCF ratio of 11.48. This is a negative value and a sign of low solvency as B4B would need 11.48 years to pay back of all of its debts.
B4B's Debt to FCF ratio of 11.48 is on the low side compared to the rest of the industry. B4B is outperformed by 66.67% of its industry peers.
B4B has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of B4B (1.80) is worse than 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 11.48
Altman-Z 2.2
ROIC/WACC0.46
WACC5.09%
B4B.DE Yearly LT Debt VS Equity VS FCFB4B.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

B4B has a Current Ratio of 0.77. This is a bad value and indicates that B4B is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of B4B (0.77) is worse than 75.00% of its industry peers.
A Quick Ratio of 0.41 indicates that B4B may have some problems paying its short term obligations.
B4B has a Quick ratio of 0.41. This is in the lower half of the industry: B4B underperforms 70.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.41
B4B.DE Yearly Current Assets VS Current LiabilitesB4B.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2024 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

B4B shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -467.16%.
Looking at the last year, B4B shows a small growth in Revenue. The Revenue has grown by 3.04% in the last year.
Measured over the past years, B4B shows a small growth in Revenue. The Revenue has been growing by 2.76% on average per year.
EPS 1Y (TTM)-467.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.67%
Revenue 1Y (TTM)3.04%
Revenue growth 3Y7.81%
Revenue growth 5Y2.76%
Sales Q2Q%5.63%

3.2 Future

B4B is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.78% yearly.
The Revenue is expected to grow by 1.12% on average over the next years.
EPS Next Y87.05%
EPS Next 2Y98.63%
EPS Next 3Y72.78%
EPS Next 5YN/A
Revenue Next Year3.17%
Revenue Next 2Y2.96%
Revenue Next 3Y2.92%
Revenue Next 5Y1.12%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
B4B.DE Yearly Revenue VS EstimatesB4B.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
B4B.DE Yearly EPS VS EstimatesB4B.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

5

4. Valuation

4.1 Price/Earnings Ratio

B4B reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 18.69 indicates a rather expensive valuation of B4B.
Based on the Price/Forward Earnings ratio, B4B is valued a bit more expensive than the industry average as 70.83% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 20.86. B4B is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 18.69
B4B.DE Price Earnings VS Forward Price EarningsB4B.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

95.83% of the companies in the same industry are more expensive than B4B, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of B4B indicates a rather cheap valuation: B4B is cheaper than 87.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.86
EV/EBITDA 3.88
B4B.DE Per share dataB4B.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

B4B's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as B4B's earnings are expected to grow with 72.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y98.63%
EPS Next 3Y72.78%

0

5. Dividend

5.1 Amount

No dividends for B4B!.
Industry RankSector Rank
Dividend Yield N/A

METRO AG

FRA:B4B (4/16/2025, 7:00:00 PM)

5.33

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)02-05 2025-02-05
Earnings (Next)05-15 2025-05-15
Inst Owners6.72%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.94B
Analysts50
Price Target5.15 (-3.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-114.86%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.59%
PT rev (3m)-2.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-149.91%
EPS NY rev (3m)-108.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.69
P/S 0.06
P/FCF 4.86
P/OCF 2.48
P/B 1.1
P/tB 4.7
EV/EBITDA 3.88
EPS(TTM)-0.5
EYN/A
EPS(NY)0.29
Fwd EY5.35%
FCF(TTM)1.1
FCFY20.57%
OCF(TTM)2.15
OCFY40.25%
SpS86.71
BVpS4.84
TBVpS1.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.41%
ROE -9.95%
ROCE 3.27%
ROIC 2.36%
ROICexc 3.32%
ROICexgc 5.01%
OM 0.58%
PM (TTM) N/A
GM 16.26%
FCFM 1.26%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-12.72%
ROICexcg growth 5Y-10.79%
ROICexc growth 3Y-15.94%
ROICexc growth 5Y-14.09%
OM growth 3Y-26.08%
OM growth 5Y-24.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.57%
GM growth 5Y-0.91%
F-Score3
Asset Turnover2.53
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 11.48
Debt/EBITDA 2.89
Cap/Depr 41.87%
Cap/Sales 1.21%
Interest Coverage 2.33
Cash Conversion 71.21%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.41
Altman-Z 2.2
F-Score3
WACC5.09%
ROIC/WACC0.46
Cap/Depr(3y)36.78%
Cap/Depr(5y)30.8%
Cap/Sales(3y)1.13%
Cap/Sales(5y)0.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-467.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.67%
EPS Next Y87.05%
EPS Next 2Y98.63%
EPS Next 3Y72.78%
EPS Next 5YN/A
Revenue 1Y (TTM)3.04%
Revenue growth 3Y7.81%
Revenue growth 5Y2.76%
Sales Q2Q%5.63%
Revenue Next Year3.17%
Revenue Next 2Y2.96%
Revenue Next 3Y2.92%
Revenue Next 5Y1.12%
EBIT growth 1Y-48.31%
EBIT growth 3Y-20.31%
EBIT growth 5Y-22.66%
EBIT Next Year398.01%
EBIT Next 3Y80.61%
EBIT Next 5Y39.25%
FCF growth 1Y73.8%
FCF growth 3Y-12.68%
FCF growth 5Y-13.49%
OCF growth 1Y39.11%
OCF growth 3Y-4.45%
OCF growth 5Y-8.74%